Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of July 8, 2025 • 9:31 PM ET
As of July 8, 2025 • 9:31 PM ET
Date/Time | Source | News Release |
---|---|---|
07/02/2025 09:40 AM EDT | Zacks | Are Medical Stocks Lagging Amarin (AMRN) This Year? |
07/01/2025 09:17 AM EDT | Zacks | Moderna Stock Gains on Encouraging Flu Vaccine Data |
06/27/2025 10:00 AM EDT | Zacks | Best Momentum Stock to Buy for June 27th |
06/25/2025 11:06 AM EDT | Zacks | Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU |
06/25/2025 10:02 AM EDT | Zacks | Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag |
06/25/2025 09:28 AM EDT | Zacks | Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock? |
06/24/2025 07:40 AM EDT | SeekingAlpha | Amarin inks licensing deal with Recordati for lead drug Vazkepa |
06/23/2025 12:34 PM EDT | Zacks | SNY Gets CHMP Nod for Expanded Use of Sarclisa in Multiple Myeloma |
06/20/2025 09:46 AM EDT | Zacks | Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid |
06/19/2025 11:11 AM EDT | Zacks | Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.